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Background / Study Objective 
• Minimally invasive surgery has been an increasingly  success in recent 
years and excellent results have been published in correlation with 
mitral valve surgery 
• In literature there is not a large series of study about minimally invasive 
tricuspid valve surgery and the outcomes after this approach have not 
been well described. Even the latest ESC/AHA guidelines have not been 
expressed about the use of minimally invasive techniques 
• In the era of increasing adoption of catheter-based treatments, this 
study analyzed our 12-year experience with minimally invasive TV 
operations. 
 
Patients 
From November 2005 to June 2018, Minimally Invasive TV surgery was 
performed in 209 patients 
Methods 
Results 1 
• Mean Cardiopulmonary bypass (CPB) time was 146.5 ± 49.5, the mean cross clamp was 90.1 ±  36.6. In 
patients with isolated tricuspid CPB time was 102.0 ± 26.9, while the mean cross clamp was 48.3 ± 31.6. 
• Conversion to sternotomy was necessary in 6 patients (2.8%), in half of the cases it occurred, at the 
beginning, as a result of tenacious adhesions.   
• Reoperation for bleeding was necessary in 19 (9.1%) cases, of which 15 were redo, and blood transfusion 
in 100 (47.8%) patients.  
• Stroke complication occurred only in 2 (0.9%) patients, PMr implantation in 15 (7.2%), hemodialysis for 
acute renal failure in 10 (4.8%), new onset of atrial fibrillation in 16 (28.1%) and groin wound infection or 
lymphocele in 5 (2.4%).   
• Mean Intensive care unit stay was 3.6 ± 11.3 days (median 1.0 day). Mean Ventilation time was 40.5 ± 
245.2 hours (median 12.0 h).  Mean hospital stay was 11,9 ± 12,8 days (median 8.0 days).  
• Overall hospital mortality was 3.8%. Intraoperative death occurred in 1 patient due to hemorrhagic 
shock. Other causes of death were multi-organ failure in 5 patients and sepsis in 2. 30- day mortality 
after TV repair was 2.1% (3/143) compared to 7.6 % (5/66) after TV replacement while after TV isolated 
procedure was 1.6% (1/61) compared to TV associated procedures 4.7% (7/148).  
• At the early postoperative TEE evaluation trivial or no regurgitation was identified.  
• Freedom from early re-operation for TV disease was 100%. 
 
Results 2 
Conclusion 
• Minimally invasive Tricuspid surgery is safe, feasible and reproducibile, 
even for hight- risk population.  
• It ensure low perioperative morbidity and mortality. It has an added 
value in case of reoperative procedures 
• In our centre it represents the gold standard and the standard 
technique of TV surgery. 
• Minimally invasive TV Surgery should be considered the benchmark for 
new hybrid catheter-based technologies 
